Efficacy of Myofunctional Therapy in Class II Patients

Status Not yet recruiting

Clinical Trial Summary

Randomized clinical trial , with a sample of 60 children with atypical swallowing, class II and with SN1 orthopedic appliances these patients were randomly divided into, group 1: 30 patients with SN1 orthopedic appliances and myofunctional therapy and group 2: 30 patients with SN1 orthopedic appliances and without myofunctional therapy.

Clinical Trial Description

Randomized clinical trial with two parallel arms, on a sample of 60 children with atypical swallowing, class II and with SN1 orthopedic appliances, these patients were randomly divided into, group 1: 30 patients with SN1 orthopedic appliances and myofunctional therapy and group 2: 30 patients with SN1 orthopedic appliances and without myofunctional therapy for the study. Both groups carried out the evaluation of the protocol that included: 1) evaluation of the dental occlusion class and skeletal classification 2) swallowing function test using the Payne technique; 3) Mioscaner analysis to measure perioral forces, i.e. tongue extension force, lip pressure, masseter contraction force. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04975672
Study type	Interventional
Source	Fundación Universitaria CIEO
Contact
Status	Not yet recruiting
Phase	N/A
Start date	December 22, 2022
Completion date	December 31, 2022

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT00944268` - Efficacy and Tolerability Study to Treat Mild and Moderate Anxiety	Phase 3
Completed	`NCT00504192` - A Phase II Study of Gemcitabine With Oxaliplatin as First Line Chemotherapy in Advanced Biliary Tract Cancer	Phase 2
Recruiting	`NCT05580159` - New Generation mRNA Booster Vaccine Against Emerging VOCs	Phase 3
Completed	`NCT05427305` - TAB008 Compared to Avastin® in Patients With EGFR Wild-type Non-squamous Non-small Cell Lung Cancer	Phase 3
Active, not recruiting	`NCT05686161` - mRNA Booster Vaccine(SW-BIC-213) Compared With Pfizer andSinopharm Against Emerging VOCs	Phase 3
Recruiting	`NCT06284746` - Tirelizumab Combined With Chemotherapy in the Treatment of HER-2 Negative Locally Advanced Gastric Cancer	Phase 2
Completed	`NCT04260113` - Apatinib for Inoperable Advanced Chondrosarcoma	N/A
Recruiting	`NCT06120712` - A Phase Ⅰb Study on Autologous GC101 TIL Injection for the Treatment of Advanced Melanoma (MIZAR-002)	Phase 1/Phase 2
Active, not recruiting	`NCT04002440` - Directed Use of REmote Patient Management System AMia to Achieve Prescribed Dry Weight	N/A
Recruiting	`NCT02693587` - Misodel or Angusta for Induction of Labour?	N/A
Completed	`NCT01194453` - Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin for Advanced NSCLC Metastatic Non-small Cell Lung Cancer	Phase 2
Recruiting	`NCT05276557` - PyloPlus Urea Breath Test System Pediatric Safety and Efficacy Study	Phase 3
Recruiting	`NCT06205758` - Efficacy and Safety Prediction of Milrinone or Levosimendan as Initial Inotropic Drug Therapy in Patients With Acute and Advanced Heart Failure With Renal Insufficiency
Recruiting	`NCT06122454` - A Phase Ic/IIb Study to Evaluate the Efficacy，Safety and Pharmacokinetics of HST in Patients With CHB	Phase 1/Phase 2
Recruiting	`NCT05913271` - Study on the Correlation Between NAT2(N-acetyltransferase2) Gene Polymorphism and CrCl(Creatine Clreance) and the Efficacy and Safety of Levosimendan in Patients With Severe Heart Failure
Recruiting	`NCT05999656` - Human Cord Blood Mononuclear Cells in the Treatment of Refractory Diabetic Foot	N/A
Recruiting	`NCT05731258` - Observational of Adjuvant Treatment of Breast Cancer With Liposomal Doxorubicin Regimen
Recruiting	`NCT03908138` - RDD Versus VDD in Newly Diagnosed Patients With Multiple Myeloma	Phase 4
Completed	`NCT05648799` - Pharmacokinetics, Safety and Efficacy Study of GP30341 (GEROPHARM, Russia) in Healthy Volunteers and Outpatients With COVID-19	N/A
Recruiting	`NCT03377933` - The Effects Probiotic Has on Gastromicroecology and Combined With Quadruple Regimen for H Pylori Infection	N/A